Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TOMM6 pseudogene 3 (TOMM6P3) is a pseudogene related to the protein-coding gene TOMM6, which encodes a component of the translocase of the outer mitochondrial membrane complex involved in mitochondrial protein import[1]. Pseudogenes are genomic loci that resemble functional genes but generally do not encode active proteins due to mutations or truncations; they often arise through gene duplication or retrotransposition events[7]. While some pseudogenes may have regulatory RNA-based functions (such as acting as competing endogenous RNAs, participating in epigenetic regulation, or affecting gene expression through various mechanisms), there is no literature or curated database evidence supporting a specific biological function, disease association, or pharmacological targeting for TOMM6P3[3][4][5][7]. Therefore, TOMM6P3 is not considered a canonical therapeutic target.
None (no evidence for direct pharmacological targeting; pseudogenes may act as miRNA sponges or via regulatory RNA networks in some cases, generally not targeted by drugs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TOMM6 pseudogene 3 (TOMM6P3).